For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240108:nRSH8562Ya&default-theme=true
RNS Number : 8562Y Eco Animal Health Group PLC 08 January 2024
8 January 2024
ECO Animal Health Group plc
("ECO" or the "Company")
Disposal of Freehold Properties
ECO Animal Health Group plc (AIM: EAH) announces that on 5 January 2024 the
Company completed the sale of its freehold property in New Malden, Surrey.
This was the former registered office of the Company and following
relocation of all functions to its office in Southgate, London, the office was
surplus and unused. The net consideration received for the sale of this
property was £831,454. The carrying value of the property was £565,000.
Additionally, on 28 November 2023, the Company's freehold property at Western
Road, Mitcham was sold to its long term occupier (an education charity) for
net consideration of £227,000. This matched its carrying value and the
previous rent payable was a peppercorn.
The total cash received from these two property sales was £1,058,454 after
fees and expenses.
The Board intends to use the majority of the net proceeds to advance the
growth aspirations of ECO. In due course, the Board also intends to use some
of the proceeds to purchase ordinary shares of the Company in the market to
cover possible future vesting of employee share-based incentives including
share options, long term incentive plans and the deferred bonus scheme. In
order to carry out such market purchases, the Company will need to seek
approval from shareholders in a general meeting.
For further information please contact:
020 8447 8899
ECO Animal Health Group plc
David Hallas (CEO)
Christopher Wilks (CFO)
Singer Capital Markets (Nominated Adviser & Joint Broker) 020 7496 3000
Phil Davies
Sam Butcher
Investec (Joint Broker) 020 7597 5970
Gary Clarence
Lydia Zychowska
Equity Developments 020 7065 2692
Hannah Crowe
Matt Evans
ICR Consilium (Investor Relations) 020 3709 5700
Mary-Jane Elliott
Isabelle Abdou
About ECO Animal Health
ECO Animal Health Group plc researches, develops and commercialises products
for livestock. Our business strategy is to generate shareholder value by
achieving the maximum sales potential from the existing product portfolio
whilst investing in Research and Development ("R&D") for new products,
particularly vaccines, and seeking to in-license new products.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DISQKPBBOBKDKDK